CAH analyst estimates
Cardinal Health (CAH) analyst ratings, the average price target and its range, and every firm's latest call.
CAH analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 20, 2026 | Mizuho Securities | Cardinal Health price target raised to $280 from $250 at Mizuho | $280.00 |
| Oct 16, 2026 | UBS | Cardinal Health price target raised to $295 from $280 at UBS | $295.00 |
| Aug 19, 2026 | RBC Capital | RBC Capital Starts Cardinal Health (CAH) at Outperform | $276.00 |
| Aug 13, 2026 | Barclays | Cardinal Health price target raised to $275 from $258 at Barclays | $275.00 |
| Aug 12, 2026 | Robert W. Baird | Cardinal Health price target raised to $274 from $251 at Baird | $274.00 |
| Aug 12, 2026 | Mizuho Securities | Cardinal Health (CAH) PT Raised to $250 at Mizuho | $250.00 |
| Aug 12, 2026 | Wells Fargo | Cardinal Health price target raised to $277 from $245 at Wells Fargo | $277.00 |
| Aug 12, 2026 | UBS | Cardinal Health price target raised to $280 from $274 at UBS | $280.00 |
| Aug 12, 2026 | Evercore ISI | Cardinal Health price target raised to $270 from $265 at Evercore ISI | $270.00 |
| Aug 12, 2026 | Morgan Stanley | Cardinal Health price target raised to $265 from $255 at Morgan Stanley | $265.00 |
| Aug 11, 2026 | Leerink Partners | Cardinal Health price target raised to $292 from $275 at Leerink | $292.00 |
| Jul 20, 2026 | UBS | Cardinal Health price target raised to $274 from $260 at UBS | $274.00 |
| May 1, 2026 | Robert W. Baird | Cardinal Health price target lowered to $248 from $257 at Baird | $248.00 |
| Apr 8, 2026 | Evercore ISI | Cardinal Health price target lowered to $240 from $260 at Evercore ISI | $240.00 |
| Mar 9, 2026 | Leerink Partners | Leerink Partners Reiterates Outperform Rating on Cardinal Health (CAH): "company is set up for solid FY2H'26 growth" | $275.00 |
- 13 firms rate CAH: 12 buy, 1 hold, 0 sell.
- The average price target is $278.22 from 9 analysts, from $265.00 to $295.00.
Updated 2026-11-02 23:11 UTC